Ming De Yu
Presidente presso Chinese Pharmaceutical Enterprises Association
Posizioni attive di Ming De Yu
Società | Posizione | Inizio | Fine |
---|---|---|---|
Chinese Pharmaceutical Enterprises Association | Presidente | 01/01/2004 | - |
China Medical Entrepreneur Association | Presidente | - | - |
Storia della carriera di Ming De Yu
Precedenti posizioni note di Ming De Yu
Società | Posizione | Inizio | Fine |
---|---|---|---|
SHANDONG WOHUA PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | 25/04/2012 | 06/01/2016 |
Independent Dir/Board Member | 25/04/2012 | 06/01/2016 | |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Direttore/Membro del Consiglio | 23/11/2009 | 01/01/2013 |
Independent Dir/Board Member | 01/08/2008 | 01/01/2013 | |
NORTH CHINA PHARMACEUTICAL COMPANY.LTD | Direttore/Membro del Consiglio | 21/05/2010 | 01/01/2012 |
Independent Dir/Board Member | 21/10/2011 | 01/01/2012 | |
Fuxin Traditional Chinese Medicine Co. | Direttore Tecnico/Scientifico/R&S | 01/01/1983 | 01/01/1983 |
Liaoning Fuxin Pharmaceutical Co. | Direttore Tecnico/Scientifico/R&S | 01/01/1983 | 01/01/1983 |
SICHUAN KELUN PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | - | - |
Beijing Pharmaceutical Group Co., Ltd.
Beijing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Pharmaceutical Group Co., Ltd. engages in the sale of Chinese medicines, chemical raw materials, chemical agents, antibiotics, biochemical drugs, and medical equipment. The company was found on March 28, 1987 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | 13/12/2010 | - |
Presidente | 16/03/2010 | 13/12/2010 | |
░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Ming De Yu
Dalian University of Technology | Undergraduate Degree |
Statistiche
Distribuzione geografica
Cina | 12 |
Posizioni
Director/Board Member | 6 |
Independent Dir/Board Member | 4 |
Chairman | 3 |
Settori
Health Technology | 7 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
3SBIO INC. | Health Technology |
NORTH CHINA PHARMACEUTICAL COMPANY.LTD | Health Technology |
SICHUAN KELUN PHARMACEUTICAL CO., LTD. | Health Technology |
SHANDONG WOHUA PHARMACEUTICAL CO., LTD. | Health Technology |
Aziende private | 6 |
---|---|
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
Beijing Pharmaceutical Group Co., Ltd.
Beijing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Pharmaceutical Group Co., Ltd. engages in the sale of Chinese medicines, chemical raw materials, chemical agents, antibiotics, biochemical drugs, and medical equipment. The company was found on March 28, 1987 and is headquartered in Beijing, China. | Health Technology |
Chinese Pharmaceutical Enterprises Association | |
China Medical Entrepreneur Association | |
Liaoning Fuxin Pharmaceutical Co. | |
Fuxin Traditional Chinese Medicine Co. |
- Borsa valori
- Insiders
- Ming De Yu
- Esperienza